Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100
Targeting a subset of stem cells shows lasting, therapeutically relevant gene editing in blood cells

Targeting a subset of stem cells shows lasting, therapeutically relevant gene editing in blood cells

A new Science Translational Medicine paper is first to report how editing a portion of stem cells with CRISPR/Cas9 is sufficient for long-term reactivation of therapeutic hemoglobin
Releases - July 31, 2019
Improving CRISPR with a heart of gold

Improving CRISPR with a heart of gold

From the Adair Lab, Clinical Research Division
Science Spotlight - July 15, 2019
Engineering B cells to bypass vaccines

Engineering B cells to bypass vaccines

From the Taylor Lab, Vaccine and Infectious Disease Division
Science Spotlight - July 15, 2019
Could gold be the key to making gene therapy for HIV and other blood disorders more accessible?

Could gold be the key to making gene therapy for HIV and other blood disorders more accessible?

A proof-of-principle study published in Nature Materials shows that gold nanoparticles loaded with CRISPR and other gene-editing tools safely and effectively edited blood stem cells. (Photos, diagram available for media use.)
Releases - May 27, 2019
Special delivery: Gold nanoparticles ship CRISPR cargo

Special delivery: Gold nanoparticles ship CRISPR cargo

Fred Hutch scientists used their new golden courier to edit genes tied to HIV, genetic blood disorders
Hutch News - May 27, 2019
Guiding inactivity of latent HIV reservoirs

Guiding inactivity of latent HIV reservoirs

From the Jerome lab, Vaccine and Infectious Disease Division
Science Spotlight - September 17, 2018
Gene therapy for sickle cell disease, and more

Gene therapy for sickle cell disease, and more

$3.7 million grant to fund novel gene therapy approach for dangerous genetic disorders of hemoglobin
Hutch News - February 02, 2017
Can gene editing cure herpes?

Can gene editing cure herpes?

Fred Hutch study shows ‘pathway to potential cure’ for herpes simplex and other latent viruses
Hutch News - September 08, 2016
CRISPR and beyond: The ins and outs of gene editing and its potential for cures

CRISPR and beyond: The ins and outs of gene editing and its potential for cures

The big 4 gene-editing platforms and how they could usher in new therapies for HIV, cancer — and other diseases
Hutch News - August 04, 2016
Last Modified, August 15, 2019